De-escalation strategies US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for De-escalation strategies. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
De-escalation strategies US Medical PG Question 1: Myeloperoxidase (MPO) is a heme-containing molecule that is found in the azurophilic granules of neutrophils. Upon release, the enzyme catalyzes hypochlorous acid production during the phagocytic response. In the setting of pneumonia, which of the following clinical findings is most directly associated with myeloperoxidase activity?
- A. Shortness of breath
- B. Green color of sputum (Correct Answer)
- C. Rust-tinged sputum
- D. Cough
- E. Fever
De-escalation strategies Explanation: ***Green color of sputum***
- Myeloperoxidase contributes to the **greenish color of sputum** due to its heme content and enzymatic activity, which involves the formation of a green pigment during the oxidation of chloride ions.
- In pneumonia, activated neutrophils release myeloperoxidase as part of the immune response, leading to the characteristic **greenish discoloration** often observed in a patient's sputum.
*Shortness of breath*
- Shortness of breath, or **dyspnea**, is a common symptom of pneumonia reflecting impaired gas exchange and increased work of breathing.
- It is a **physiological response** to lung inflammation and consolidation, not a direct end result of myeloperoxidase activity.
*Rust-tinged sputum*
- **Rust-tinged sputum** is classically associated with **Streptococcus pneumoniae** pneumonia and is due to the breakdown of red blood cells and the presence of hemoglobin metabolites.
- While it indicates an infection, it is not directly linked to the enzymatic action or color of myeloperoxidase itself.
*Cough*
- **Cough** is a vital **protective reflex** in pneumonia, aiming to clear respiratory secretions and foreign material from the airways.
- It is a symptom of airway irritation and inflammation, rather than a direct visual outcome of biochemical reactions involving myeloperoxidase.
*Fever*
- **Fever** is a systemic manifestation of the body's generalized **inflammatory response** to infection, mediated by pyrogens.
- It is a non-specific symptom indicating an active infection, not a direct consequence of myeloperoxidase activity or its visual manifestation.
De-escalation strategies US Medical PG Question 2: An investigator is studying the chemical structure of antibiotics and its effect on bacterial growth. He has synthesized a simple beta-lactam antibiotic and has added a bulky side chain to the molecule that inhibits the access of bacterial enzymes to the beta-lactam ring. The synthesized drug will most likely be appropriate for the treatment of which of the following conditions?
- A. Folliculitis (Correct Answer)
- B. Nocardiosis
- C. Atypical pneumonia
- D. Erythema migrans
- E. Otitis media
De-escalation strategies Explanation: ***Folliculitis***
- The bulky side chain provides **steric hindrance** that prevents **staphylococcal beta-lactamases** from accessing and degrading the **beta-lactam ring**.
- This modification creates an **anti-staphylococcal penicillin** (similar to methicillin, nafcillin, or oxacillin), which is effective against **methicillin-sensitive *Staphylococcus aureus* (MSSA)**.
- **Folliculitis** is most commonly caused by *S. aureus*, making this modified beta-lactam an appropriate treatment choice for MSSA-related folliculitis.
- The bulky side chain specifically protects against the **penicillinase** (beta-lactamase) produced by staphylococci.
*Otitis media*
- Otitis media is commonly caused by beta-lactamase-producing organisms like *Haemophilus influenzae* and *Moraxella catarrhalis*.
- However, the beta-lactamases produced by these gram-negative organisms are **not inhibited by bulky side chains** alone.
- Treatment of beta-lactamase-producing *H. influenzae* and *M. catarrhalis* requires **beta-lactamase inhibitors** (such as clavulanic acid combined with amoxicillin), not steric hindrance.
- The mechanism of protection differs: beta-lactamase inhibitors **suicide inhibitors** that bind to the enzyme, whereas bulky side chains provide **physical blocking**.
*Nocardiosis*
- Nocardiosis is caused by *Nocardia* species, which are **aerobic actinomycetes**.
- These bacteria are typically treated with **sulfonamides** (trimethoprim-sulfamethoxazole) for prolonged periods.
- Beta-lactam antibiotics are generally not first-line treatment, as *Nocardia* species often show intrinsic resistance or require specific antibiotic combinations.
*Atypical pneumonia*
- Atypical pneumonia is caused by organisms like *Mycoplasma pneumoniae*, *Chlamydophila pneumoniae*, and *Legionella pneumophila*.
- These organisms lack a **peptidoglycan cell wall**, which is the target of all **beta-lactam antibiotics**.
- Beta-lactams (regardless of modifications) are completely ineffective against atypical pneumonia pathogens.
- Treatment requires **macrolides** (azithromycin), **tetracyclines** (doxycycline), or **fluoroquinolones**.
*Erythema migrans*
- Erythema migrans is the characteristic rash of early **Lyme disease**, caused by *Borrelia burgdorferi*.
- While *Borrelia* is sensitive to certain beta-lactam antibiotics (amoxicillin, ceftriaxone), it does **not produce beta-lactamases**.
- The bulky side chain modification is unnecessary for treating *Borreria* infections, as there is no beta-lactamase to protect against.
- Standard treatment uses doxycycline, amoxicillin, or ceftriaxone—not anti-staphylococcal penicillins.
De-escalation strategies US Medical PG Question 3: A 59-year-old woman comes to the emergency department because of a 2-day history of worsening fever, chills, malaise, productive cough, and difficulty breathing. Three days ago, she returned from a trip to South Africa. She has type 2 diabetes mellitus, hypertension, and varicose veins. Her current medications include metformin, lisinopril, and atorvastatin. Her temperature is 39.4°C (102.9°F), pulse is 102/minute, blood pressure is 94/68 mm Hg, and respirations are 31/minute. Pulse oximetry on 2 L of oxygen via nasal cannula shows an oxygen saturation of 91%. Examination reveals decreased breath sounds and dull percussion over the left lung base. The skin is very warm and well-perfused. The remainder of the examination shows no abnormalities. Laboratory studies show:
Hemoglobin 11.6 g/dL
Leukocyte count 15,400/mm3
platelet count 282,000/mm3
Serum
Na+ 144 mEq/L
Cl- 104 mEq/L
K+ 4.9 mEq/L
Creatinine 1.5 mg/dL
Blood and urine for cultures are obtained. Intravenous fluid resuscitation is begun. Which of the following is the next best step in management?
- A. Erythromycin
- B. Intravenous ceftriaxone and azithromycin (Correct Answer)
- C. External cooling and intravenous acetaminophen
- D. Intravenous vancomycin and ceftriaxone
- E. CT of the chest with contrast
De-escalation strategies Explanation: ***Intravenous ceftriaxone and azithromycin***
* This patient presents with **severe community-acquired pneumonia (CAP)** meeting criteria for ICU-level care, including hypotension (94/68 mm Hg), hypoxemia requiring supplemental oxygen, tachypnea (31/min), and altered mental status indicators. The presentation meets multiple **severe CAP criteria** (CURB-65 score ≥3 or IDSA/ATS major criteria).
* **Intravenous ceftriaxone** (a third-generation cephalosporin) provides broad-spectrum coverage against common bacterial causes of CAP, including *Streptococcus pneumoniae* and *Haemophilus influenzae*. **Azithromycin** (a macrolide) is crucial to cover atypical pathogens like *Mycoplasma pneumoniae*, *Chlamydophila pneumoniae*, and *Legionella pneumoniae*.
* This combination represents the **standard empiric therapy for severe CAP** per IDSA/ATS guidelines. The patient's recent travel to South Africa and severe symptoms increase the likelihood of atypical pathogens or resistant strains, making dual therapy essential.
*Erythromycin*
* While erythromycin is a macrolide that covers atypical pathogens, its use is generally limited due to higher rates of gastrointestinal side effects and a less favorable dosing profile compared to newer macrolides like azithromycin. It does not provide adequate coverage for typical bacterial causes of CAP.
* In severe CAP with signs of sepsis, monotherapy with erythromycin would be insufficient and would not address the need for broad-spectrum coverage against both typical and atypical bacteria. Dual antibiotic therapy is required for severe cases.
*External cooling and intravenous acetaminophen*
* These interventions are appropriate for **fever reduction** but do not address the underlying severe infection (pneumonia with sepsis). While important for symptomatic relief, they are not the "next best step in management" for a life-threatening condition.
* Treating the infection with appropriate antibiotics is paramount to prevent further deterioration and organ damage. In severe sepsis from pneumonia, **source control through antimicrobial therapy takes precedence** over symptomatic fever management.
*Intravenous vancomycin and ceftriaxone*
* **Vancomycin** is primarily used to cover **methicillin-resistant *Staphylococcus aureus* (MRSA)**. While MRSA can cause severe pneumonia, there are no specific risk factors for MRSA in this patient (e.g., recent hospitalization, IV drug use, prior MRSA infection, severe influenza, cavitary lesions, hemoptysis).
* Adding vancomycin without specific indications for MRSA coverage would represent unnecessary broad-spectrum antibiotic use and could contribute to antibiotic resistance. The combination of **ceftriaxone and azithromycin is the standard empiric therapy** for severe CAP without MRSA risk factors.
*CT of the chest with contrast*
* A CT scan of the chest might be useful for further characterizing the pneumonia, identifying complications (e.g., empyema, abscess), or differentiating from other conditions **after initial stabilization**. However, in a patient with severe pneumonia, hypoxemia, and hypotension, the immediate priority is stabilization and initiation of empiric antibiotic therapy.
* Delaying life-saving antibiotic treatment to obtain a CT scan could worsen the patient's prognosis and violate the principle of **early appropriate antibiotics in sepsis** (ideally within 1 hour). Clinical diagnosis with chest X-ray is sufficient to initiate treatment, and further imaging can be obtained after stabilization if needed.
De-escalation strategies US Medical PG Question 4: A 77-year-old woman is brought to the emergency department from her nursing home because she was found down overnight. On presentation she was found to be delirious and was unable to answer questions. Chart review shows that she is allergic to cephalosporins. Her temperature is 102.2°F (39°C), blood pressure is 105/52 mmHg, pulse is 94/min, and respirations are 23/min. Physical exam reveals a productive cough. A metabolic panel is obtained with the following results:
Serum:
Na+: 135 mEq/L
Cl-: 95 mEq/L
K+: 4 mEq/L
HCO3-: 19 mEq/L
BUN: 40 mg/dL
Creatinine: 2.5 mg/dL
Glucose: 150 mg/dL
Based on these findings two different drugs are started empirically. Gram stain on a blood sample is performed showing the presence of gram-positive organisms on all samples. One of the drugs is subsequently stopped. The drug that was most likely stopped has which of the following characteristics?
- A. Resistance conveyed through acetylation
- B. Associated with red man syndrome
- C. Single-ringed ß-lactam structure (Correct Answer)
- D. Causes discolored teeth in children
- E. Accumulates inside bacteria via O2-dependent uptake
De-escalation strategies Explanation: ***Single-ringed ß-lactam structure***
- The patient presents with **sepsis** due to **pneumonia** likely caused by **gram-positive organisms**. Given a cephalosporin allergy, **aztreonam** (a monobactam) would be an initial empirical antibiotic choice to cover gram-negative bacteria, alongside a drug for gram-positive coverage (like vancomycin).
- Since the **blood cultures** confirmed **gram-positive organisms**, the drug covering gram-negative bacteria (aztreonam) would be stopped. Aztreonam is characterized by its **single-ringed β-lactam structure**.
*Resistance conveyed through acetylation*
- This mechanism of resistance is typical of **aminoglycosides** (e.g., gentamicin) and **chloramphenicol**.
- Aminoglycosides were unlikely to be one of the empirically started drugs, as they are often used in combination with β-lactams, and this patient has a cephalosporin allergy.
*Associated with red man syndrome*
- **Red man syndrome** is a common adverse effect associated with **vancomycin** administration, especially with rapid infusion.
- Vancomycin would likely be continued, as it effectively targets gram-positive organisms, including **MRSA**, and is a suitable alternative given the cephalosporin allergy.
*Causes discolored teeth in children*
- This is a characteristic side effect of **tetracyclines** (e.g., doxycycline), which are contraindicated in young children and pregnant women due to their effects on bone and teeth development.
- Tetracyclines are not typically first-line empiric therapy for severe pneumonia or sepsis, especially in an elderly patient.
*Accumulates inside bacteria via O2-dependent uptake*
- This describes the mechanism of uptake for **aminoglycosides**. Their entry into bacteria is an **energy-dependent process** requiring oxygen.
- As mentioned, aminoglycosides are less likely to be the initial drug stopped in this scenario, as they target gram-negative bacteria.
De-escalation strategies US Medical PG Question 5: A 15-year-old boy presents with his father to the urgent care with 5 days of frequent diarrhea, occasionally with streaks of blood mixed in. Stool cultures are pending, but preliminary stool samples demonstrate fecal leukocytes and erythrocytes. His vital signs are as follows: blood pressure is 126/83 mm Hg, heart rate is 97/min, and respiratory rate is 15/min. He is started on outpatient therapy for presumed Shigella infection. Which of the following is the most appropriate therapy?
- A. Oral doxycycline
- B. Oral vancomycin
- C. Oral TMP-SMX
- D. Oral azithromycin (Correct Answer)
- E. Oral ciprofloxacin
De-escalation strategies Explanation: ***Oral azithromycin***
- **Azithromycin** is the **first-line empiric treatment** for suspected **Shigella infection** based on current CDC and WHO guidelines, particularly in pediatric and adolescent patients.
- The presence of **fecal leukocytes and erythrocytes** indicates an invasive bacterial infection, which warrants antibiotic therapy to shorten the course of illness and reduce transmission risks.
- Azithromycin has excellent efficacy against Shigella with relatively low resistance rates compared to older agents, and it is well-tolerated in adolescents.
*Oral TMP-SMX*
- **TMP-SMX (trimethoprim-sulfamethoxazole)** was historically first-line for Shigella, but **widespread resistance** (often >50% globally) has made it no longer recommended for empiric therapy.
- It may still be used if culture and susceptibility testing confirm sensitivity, but should not be chosen empirically.
*Oral ciprofloxacin*
- **Ciprofloxacin**, a fluoroquinolone, is highly effective against **Shigella** and is first-line in adults.
- However, its use in **pediatric patients under 18 years** is generally limited due to potential adverse effects on **cartilage development** and risk of tendinopathy.
- In a 15-year-old, while approaching adult age, azithromycin remains preferred unless there are specific contraindications.
*Oral doxycycline*
- **Doxycycline** has limited activity against **Shigella** and is not considered appropriate empiric therapy for this infection.
- It is more commonly used for atypical pathogens, certain sexually transmitted infections, or specific tick-borne diseases.
*Oral vancomycin*
- **Oral vancomycin** is primarily used to treat **Clostridioides difficile infection** (CDI) and is completely ineffective against **Shigella**.
- Vancomycin acts only on gram-positive bacteria and does not penetrate the systemic circulation when given orally, making it unsuitable for gram-negative enteric infections.
De-escalation strategies US Medical PG Question 6: A 26-year-old nurse presents 12 hours after she accidentally stuck herself with a blood-contaminated needle. She reported the accident appropriately and now seeks post-exposure prophylaxis. She does not have any complaints at the moment of presentation. Her vital signs include: blood pressure 125/80 mm Hg, heart rate 71/min, respiratory rate 15/min, and temperature 36.5℃ (97.7℉). Physical examination is unremarkable. The nurse has prescribed a post-exposure prophylaxis regimen which includes tenofovir, emtricitabine, and raltegravir. How will tenofovir change the maximum reaction rate (Vm) and Michaelis constant (Km) of the viral reverse transcriptase?
- A. Vm will decrease, Km will increase
- B. Vm and Km will both decrease
- C. Vm will stay the same, Km will increase
- D. Vm and Km will both increase
- E. Vm will decrease, Km will stay the same (Correct Answer)
De-escalation strategies Explanation: ***Vm will decrease, Km will stay the same***
- **Tenofovir** is a **nucleotide reverse transcriptase inhibitor (NtRTI)** that acts as a **competitive substrate analog**. Once phosphorylated to **tenofovir diphosphate**, it competes with natural deoxyadenosine triphosphate (dATP) for incorporation into the viral DNA chain.
- Upon incorporation, tenofovir acts as a **chain terminator** because it lacks a 3'-hydroxyl group necessary for further DNA elongation. This **irreversibly inactivates** the enzyme-DNA complex, effectively reducing the **maximum reaction rate (Vm)** by decreasing the amount of functional enzyme available.
- Since tenofovir competes with natural nucleotides but doesn't affect the enzyme's affinity for its natural substrates, the **Michaelis constant (Km) remains unchanged**. The inhibition pattern shows characteristics of competitive inhibition with irreversible chain termination.
*Vm will decrease, Km will increase*
- This pattern is characteristic of a **mixed inhibitor**, where the inhibitor can bind to both the free enzyme and the enzyme-substrate complex, reducing Vm while also decreasing substrate affinity (increasing Km).
- While tenofovir does reduce Vm through chain termination, it does not significantly alter the enzyme's affinity for natural nucleotide substrates. Tenofovir diphosphate **competes directly** with dATP rather than binding to an allosteric site, so Km remains unchanged rather than increasing.
*Vm and Km will both decrease*
- This effect is typical of an **uncompetitive inhibitor**, which binds only to the **enzyme-substrate complex**. Uncompetitive inhibitors decrease both Vm and Km, implying increased apparent substrate affinity.
- Tenofovir does not function as an uncompetitive inhibitor. As a **nucleotide analog**, it competes for the active site and gets incorporated into DNA, causing chain termination. This mechanism does not involve preferential binding to the enzyme-substrate complex that would decrease Km.
*Vm will stay the same, Km will increase*
- This describes **pure reversible competitive inhibition**, where the inhibitor competes with substrate for the active site but can be overcome by increasing substrate concentration, leaving Vm unchanged.
- While tenofovir diphosphate does **compete with natural nucleotides**, it acts as a **suicide substrate** that causes irreversible chain termination once incorporated. This **permanently inactivates** the enzyme-DNA complex, reducing the pool of functional enzyme and thus decreasing Vm, distinguishing it from simple reversible competitive inhibition.
*Vm and Km will both increase*
- An increase in both Vm and Km is not a standard pattern for enzyme inhibition and would suggest **reduced substrate affinity** with paradoxically increased catalytic capacity, which is inconsistent with any inhibitory mechanism.
- This scenario contradicts the **intended therapeutic effect** of tenofovir, which is to inhibit HIV reverse transcriptase activity and prevent viral replication, not to enhance enzyme function.
De-escalation strategies US Medical PG Question 7: A 38-year-old female presents to the emergency room with fevers, fatigue, and anorexia for over a month. Past medical history includes mild mitral valve prolapse. She underwent an uncomplicated tooth extraction approximately 6 weeks ago. Her vital signs include a temperature of 100.8 F, pulse of 83, blood pressure of 110/77, and SpO2 of 97% on room air. On exam, you note a grade III/VI holosystolic murmur at the apex radiating to the axilla as well as several red, painful nodules on her fingers. Which of the following is the next best course of action?
- A. Blood cultures are not needed. Start empiric antibiotics
- B. Start anticoagulation with heparin
- C. Consult cardiothoracic surgery for mitral valve replacement
- D. Obtain blood cultures x3 sites over 24 hours and start antibiotics after culture results are available
- E. Obtain blood cultures x3 sites over 1 hour and start empiric antibiotics (Correct Answer)
De-escalation strategies Explanation: ***Obtain blood cultures x3 sites over 1 hour and start empiric antibiotics***
- The patient's presentation with **fever, fatigue, anorexia, new murmur, and painful finger nodules (Osler's nodes)** after a recent dental procedure strongly suggests **infective endocarditis**. Prompt initiation of **empiric antibiotics** after obtaining adequate blood cultures is crucial to improve outcomes and prevent further complications like septic emboli or valvular damage.
- Obtaining **multiple blood cultures rapidly (e.g., three sets over 1 hour)** from different sites maximizes the chance of isolating the causative organism before antibiotics are given, enabling targeted therapy later, while minimizing delay to treatment.
*Blood cultures are not needed. Start empiric antibiotics*
- **Blood cultures are essential** for diagnosing infective endocarditis, identifying the causative organism, and guiding appropriate antibiotic therapy. Skipping blood cultures could lead to inappropriate antibiotic selection and treatment failure.
- While empiric antibiotics are warranted, they should always be initiated **after blood cultures** have been drawn to avoid sterilizing the blood and making microbial identification difficult.
*Start anticoagulation with heparin*
- **Anticoagulation is generally contraindicated** in infective endocarditis due to the increased risk of hemorrhagic complications, especially in cases of septic emboli to the brain.
- While patients with endocarditis can form vegetations that may embolize, the risks of **bleeding outweigh the benefits** of routine anticoagulation.
*Consult cardiothoracic surgery for mitral valve replacement*
- While **mitral valve prolapse** is a risk factor for endocarditis and severe valvular damage may eventually require surgery, primary management involves **antibiotic therapy**.
- Surgical intervention is typically reserved for cases with **severe valvular regurgitation/stenosis leading to heart failure**, uncontrolled infection despite antibiotics, or recurrent emboli, and is not the immediate next step.
*Obtain blood cultures x3 sites over 24 hours and start antibiotics after culture results are available*
- Waiting for **24 hours to collect blood cultures** would significantly delay the initiation of antibiotics, which is dangerous in a potentially life-threatening infection like endocarditis.
- Delaying antibiotics until **culture results are available** could take several days, leading to worsening infection, organ damage, and increased mortality. **Empiric antibiotics** must be started promptly after initial blood collection.
De-escalation strategies US Medical PG Question 8: A 38-year-old previously healthy woman develops septic shock from necrotizing fasciitis of the lower extremity. Despite three debridements, broad-spectrum antibiotics (vancomycin, meropenem, clindamycin), IVIG, and aggressive critical care support, she develops refractory shock requiring norepinephrine 1.2 mcg/kg/min, vasopressin 0.04 units/min, and epinephrine 0.1 mcg/kg/min. Lactate is 15 mmol/L. Surgical team recommends hemipelvectomy as last option for source control. Family is devastated. ICU team notes SOFA score of 18. Synthesize an approach to management and decision-making.
- A. Transfer to ECMO center for consideration of VA-ECMO as bridge to hemipelvectomy
- B. Multidisciplinary meeting with surgery, ICU, palliative care, and family to discuss realistic outcomes, quality of life, and patient values before decision (Correct Answer)
- C. Continue medical management for 24 hours and proceed with hemipelvectomy only if shock improves
- D. Decline surgery based on futility given SOFA score >15 and initiate comfort care
- E. Proceed with hemipelvectomy immediately as only chance for survival with informed consent from family
De-escalation strategies Explanation: ***Multidisciplinary meeting with surgery, ICU, palliative care, and family to discuss realistic outcomes, quality of life, and patient values before decision***
- In high-acuity cases with refractory shock and high **SOFA scores (>15)**, shared decision-making is essential to align surgical intervention with the patient’s **goals of care**.
- This approach ensures that the **prognosis**, which carries a high risk of mortality and morbidity from **hemipelvectomy**, is transparently communicated by the entire medical team.
*Transfer to ECMO center for consideration of VA-ECMO as bridge to hemipelvectomy*
- **VA-ECMO** is generally not indicated in septic shock with refractory vasoplegia and severe multi-organ failure as it doesn't solve the **source control** issue.
- The logistics and physiological stress of a transfer in the setting of **1.2 mcg/kg/min norepinephrine** would be highly unstable and likely fatal.
*Continue medical management for 24 hours and proceed with hemipelvectomy only if shock improves*
- Delaying source control in **necrotizing fasciitis** while shock is worsening usually leads to death, as medical management alone cannot overcome the focus of infection.
- Waiting for improvement in the setting of a **lactate of 15 mmol/L** and triple vasopressors is unrealistic without definitive surgical intervention.
*Decline surgery based on futility given SOFA score >15 and initiate comfort care*
- While the **SOFA score** indicates a very high mortality risk, unilateral physician declaration of **medical futility** is ethically complex and can damage family trust.
- Comfort care should remain a possibility, but first requires a thorough **interdisciplinary discussion** to ensure legal and ethical standards are met.
*Proceed with hemipelvectomy immediately as only chance for survival with informed consent from family*
- Performing such a **mutilating surgery** without a detailed discussion of the expected **quality of life** and long-term functional loss is poor surgical practice.
- Immediate surgery without addressing the massive **operative mortality** risk ignores the patient's potential preference for a dignified death over a futile procedure.
De-escalation strategies US Medical PG Question 9: A 52-year-old woman with septic shock from intra-abdominal infection undergoes emergency exploratory laparotomy for perforated diverticulitis with fecal peritonitis. Surgery reveals extensive contamination requiring damage control approach. Postoperatively, she requires norepinephrine 0.8 mcg/kg/min plus vasopressin 0.04 units/min, has lactate of 8.5 mmol/L, temperature 35.2°C, INR 2.8, pH 7.18, and base deficit -12. Planned return to OR is in 48 hours. Evaluate the priority interventions to optimize outcome.
- A. Immediate return to OR for definitive repair and anastomosis
- B. Start therapeutic hypothermia and delay reoperation until hemodynamically stable off vasopressors
- C. Initiate high-dose vasopressors to maintain MAP >75 mmHg and early enteral nutrition
- D. Administer massive transfusion protocol and emergency re-exploration within 6 hours
- E. Aggressive rewarming, correction of coagulopathy, ongoing resuscitation, and source control at planned reoperation (Correct Answer)
De-escalation strategies Explanation: ***Aggressive rewarming, correction of coagulopathy, ongoing resuscitation, and source control at planned reoperation***
- This patient presents with the **lethal triad** (coagulopathy, acidosis, and hypothermia) in the setting of **septic shock**, necessitating physiologic stabilization before definitive surgery.
- The gold standard for **damage control** is to stabilize the patient in the ICU by correcting **base deficit**, improving **lactate clearance**, and restoring normal temperature and coagulation parameters.
*Immediate return to OR for definitive repair and anastomosis*
- Attempting **definitive repair** or anastomosis in an unstable patient with fecal peritonitis and high-dose **vasopressor requirements** carries a prohibited risk of dehiscence and death.
- Surgery should be limited to **staged re-intervention** only after the metabolic and physiologic insults have been partially reversed.
*Start therapeutic hypothermia and delay reoperation until hemodynamically stable off vasopressors*
- **Hypothermia** is a component of the lethal triad that worsens **coagulopathy** by inhibiting the clotting cascade; metabolic rewarming is required, not cooling.
- While stability is the goal, waiting to be completely off vasopressors might dangerously delay **source control** if the infection is driving the shock.
*Initiate high-dose vasopressors to maintain MAP >75 mmHg and early enteral nutrition*
- Focus should be on **volume resuscitation** and reversing tissue hypoxia (lactate) rather than solely escalating vasopressors, which can cause **mesenteric ischemia**.
- **Early enteral nutrition** is contraindicated in the immediate postoperative phase of an open abdomen with significant **hemodynamic instability** and high pressor requirements.
*Administer massive transfusion protocol and emergency re-exploration within 6 hours*
- **Massive transfusion protocol** is typically reserved for active, uncontrolled hemorrhage, whereas this patient primarily requires reversal of **septic shock** and metabolic derangements.
- **Re-exploration within 6 hours** is too early for a damage control patient who has not yet been adequately rewarmed or had their **acidosis** corrected.
De-escalation strategies US Medical PG Question 10: A 70-year-old man with recently diagnosed small cell lung cancer presents with septic shock from pneumonia. After initial resuscitation, he requires norepinephrine 0.6 mcg/kg/min and has a lactate of 7.8 mmol/L. His SOFA score is 14. The family requests 'everything be done,' but the patient had previously told his oncologist he would not want prolonged intensive care if his cancer prognosis was poor. Staging shows extensive-stage disease. The ICU team debates goals of care. What represents the most ethically appropriate approach to decision-making?
- A. Continue maximum therapy per family wishes as they are legal decision-makers
- B. Obtain ethics consultation to overrule family wishes based on futility
- C. Arrange urgent palliative care consultation and family meeting to discuss patient's previously expressed wishes and realistic prognosis (Correct Answer)
- D. Continue current therapy for 72 hours then reassess based on clinical trajectory
- E. Transition to comfort care based on poor oncologic prognosis and high SOFA score
De-escalation strategies Explanation: ***Arrange urgent palliative care consultation and family meeting to discuss patient's previously expressed wishes and realistic prognosis***
- The most ethically sound approach is to use **substituted judgment**, which prioritizes the patient's **previously expressed wishes** about avoiding prolonged intensive care.
- A **multidisciplinary family meeting** helps reconcile medical reality with patient values, ensuring informed **shared decision-making** rather than a unilateral or discordant approach.
*Continue maximum therapy per family wishes as they are legal decision-makers*
- While families are **surrogate decision-makers**, their role is to advocate for what the **patient would want**, not their own personal desires.
- Blindly following "everything be done" ignores the patient's prior statement to his oncologist and risks providing **non-beneficial treatment**.
*Obtain ethics consultation to overrule family wishes based on futility*
- The term **medical futility** is often controversial; ethics consultations are designed to **mediate conflicts** rather than simply provide a mechanism to overrule families.
- Unilateral decisions should only follow exhaustive attempts at **communication and mediation**, which have not yet occurred in this case.
*Continue current therapy for 72 hours then reassess based on clinical trajectory*
- A "time-limited trial" is a valid tool but fails to address the immediate ethical conflict regarding the **patient's autonomous refusal** of prolonged care.
- This approach may unnecessarily prolong the dying process and ignore the **prognostic alignment** required between the oncology and ICU teams.
*Transition to comfort care based on poor oncologic prognosis and high SOFA score*
- Clinicians should not unilaterally transition to **comfort care** without discussing the patient's prognosis and values with the family/surrogates first.
- While the **high SOFA score** and extensive cancer indicate a poor prognosis, the process must respect the legal and ethical requirements of **informed consent and withdrawal of care**.
More De-escalation strategies US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
